In this short blog post, we cover the latest happenings around CRISPR and other technologies.
New CRISPR Tool Can Precisely Tackle a Number of Genetic Diseases
A new genome editing method, called prime editing, improves efficiency and product purity compared to base editing and has lower off-target editing. Prime editing overcomes the problems of CRISPR-Cas9 by having the Cas9 enzyme in the tool to nick only one strand of DNA. To read more, click here.
Russian Scientist to Alter the Deaf Gene by Editing Human Eggs
Denis Rebrikov, a Russian biologist, will wait for regulatory approval to begin gene editing of human eggs to understand how deaf couples can give birth to children without any hearing disability. Using CRISPR, he plans to edit the gene GJB2, which causes a genetic mutation resulting in deafness. To read more, click here.
Largest CRISPR-Cas9 Patent Portfolio Held by UC
With the grant of U.S. Patent No. 10,428,352, the University of California holds 16 CRISPR-Cas9 patents in its portfolio, which is the largest such portfolio in the US. It could increase to 18 in the coming weeks. To read more, click here.
Want to learn about MaxVal’s CRISPR-CAS9 landscape? Check out our live report here.